Abstract: A system for changing width of a person support apparatus is disclosed. A person support apparatus comprises at least one deck extension which is configured to be retracted or extended by at least one motor controlled by a bed controller. A mattress controller communicates with a bed controller and controls a fluid supply device to inflate or deflate a mattress supported by the person support apparatus to alter the width of the mattress. The mattress may also be inflated or deflated in response to manual extension or retraction of the deck extension.

Abstract: An incontinence detection system includes an incontinence detection pad underneath a patient's pelvic area for detecting an incontinence event. The incontinence detection system further includes a moisture detection sensor, a gas detection sensor, and a reader. The moisture detection sensor is embedded in the incontinence detection pad for detecting a presence of moisture in incontinence detection pad. The gas detection sensor is positioned near the incontinence detection pad for detecting a presence of targeted gas, such as methane. The reader is communicatively coupled to the moisture detection sensor and the gas detection sensor to receive moisture data and gas data, respectively. The reader is configured to determine a type of the incontinence event based on the received moisture data and the gas data and transmit a signal indicative of the type of incontinence event to a server.

Abstract: An incontinence detection system includes an incontinence detection pad underneath a patient's pelvic area for detecting an incontinence event. The incontinence detection system further includes a moisture detection sensor, a gas detection sensor, and a reader. The moisture detection sensor is embedded in the incontinence detection pad for detecting a presence of moisture in incontinence detection pad. The gas detection sensor is positioned near the incontinence detection pad for detecting a presence of targeted gas, such as methane. The reader is communicatively coupled to the moisture detection sensor and the gas detection sensor to receive moisture data and gas data, respectively. The reader is configured to determine a type of the incontinence event based on the received moisture data and the gas data and transmit a signal indicative of the type of incontinence event to a server.

Abstract: The present disclosure include devices, systems, and methods for location-based incontinence detection and monitoring including a communication device receiving incontinence event indicators occurrence and location indicators.

Abstract: The present disclosure include devices, systems, and methods for location-based incontinence detection and monitoring including a communication device receiving incontinence event indicators occurrence and location indicators.

Abstract: A system for changing width of a person support apparatus is disclosed. A person support apparatus comprises at least one deck extension which is configured to be retracted or extended by at least one motor controlled by a bed controller. A mattress controller communicates with a bed controller and controls a fluid supply device to inflate or deflate a mattress supported by the person support apparatus to alter the width of the mattress. The mattress may also be inflated or deflated in response to manual extension or retraction of the deck extension.

Abstract: The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the A ring of the steroidal ring system is optionally substituted at position 2 or 4 with a group R4 which may be a suitable subtituent, wherein the D ring of the steroidal ring system is substituted by a group R2 of the formula -L-R3, wherein L is an optional linker group and R3 is selected from groups which are or which comprise one of (i) —SO2R5, wherein R5 is H, a hydrocarbyl group or a bond or group attached to the D ring; (ii) —NO2; (iii) —SOR6, wherein R6 is H or a hydrocarbyl group; (iv) —R7, wherein R7 is a halogen; (v) -alkyl; (vi) —C(?O)R3, wherein R3 is H or hydrocarbyl; (vii) —C?CR9, wherein R9 is H or hydrocarbyl; (viii) —OC(?O)NR10R11 wherein R10 and R11 are independently selected from H and hydrocarbyl; (ix), (x), (xi), (xii) and (xiii) are formula

Abstract: There is provided a compound having Formula (I) wherein G is H or a substituent, and wherein R1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group, capable of inhibiting steroid sulphatase.

Abstract: There is provided a compound of Formula (I) wherein (I) R2 is selected from (i) an alkyloxyalkyl group (ii) a nitrile group, and wherein R2 is capable of forming a hydrogen bond (iii) alkylaryl group, wherein the aryl group is substituted by other than a C1-10 group (iv) alkenylaryl group wherein the aryl group is substituted (v) alkylheteroaryl group, wherein when heteroaryl group comprises only C and N in the ring, the aryl group is substituted by other than a methyl group (vi) alkenylheteroaryl group, (vii) ?N—O-alkyl or ?N—O—H group (viii) branched alkenyl (ix) alkyl-alcohol group (x) amide or alkylamide wherein (a) the alkyl of the alkylamide is —CH2— or —Ch2Ch2—, (b) the amide is di-substituted and/or (c) the amide is substituted with at least one of alkyl heterocycle group, alkenyl heterocycle group, alkylheteroaryl group, alkenylheteroaryl group, heteroaryl group, alkylamine group, alkyloxyalkyl group, alkylaryl group, straight or branched alkyl group, (xi) —CHO so that R1 together with R3 provide the

Abstract: A method of inhibiting steroid sulphatase activity in a subject in need of same is described.

Abstract: A method of inhibiting steroid sulphatase activity in a subject in need of same as described. The method comprises administering to said subject a steroid sulphatase inhibiting amount of a ring system compound; which ring system compound comprises a ring to which is attached a sulphamate group of the formula wherein each of R1 and R2 is independently selected from H, alkyl, alkenyl, cycloalkyl and aryl, or together represent alkylene optionally containing one or more hetero atoms or groups in the alkylene chain; and wherein said compound is an inhibitor of an enzyme having steroid sulphatase activity (E.C.3.1.6.2); and if the sulphamate group of said compound is replaced with a sulphate group to form a sulphate compound and incubated with a steroid sulphatase enzyme (E.C.3.1.6.2) at a pH 7.4 and 37° C. it would provide a Km value of less than 50 &mgr;M.